Partnerships and collaborations

Our mission at xCures is to help patients and oncologists utilize any and all resources to fight advanced cancer. As a technology platform, we offer information and decision support directly to patients and oncologists. We also connect them with third-party resources from some of the best ‘patient first’ organizations to expand treatment options and services.

  • BioMed Valley Discoveries

    xCures partnered with BioMed Valley Discoveries to offer expanded access to ulixertinib, a first-in-class ERK1/2 inhibitor, for patients with advanced solid tumors who are no longer responding to or have exhausted standard of care. Learn More

    Visit BioMed Valley Discoveries

  • BioSpark

    xCures partnered with BioSpark to rapidly expand the scope of real-world oncology data and help patients and their physicians understand the best treatment options

    Visit BioSpark

  • Cellworks

    xCures has partnered with Cellworks to advance predictive algorithms based on molecular systems biology and personalize oncology through multi-omic therapy biosimulation.

    Visit Cellworks

  • Cancer Commons

    Cancer Commons is a nonprofit that provides hope to advanced cancer patients by offering a highly customized and personal experience and helping them quickly identify and access their best possible treatment.

    Visit Cancer Commons

  • CancerCompass

    xCures is collaborating with CancerCompass to allow consumers who contact CancerCompass to get immediate help as well as premium access to the xCures platform and services.

    Visit CancerCompass


    xCures collaborates with COLONTOWN in creating a comprehensive precision medicine resource for COLONTOWN University.


  • CureScience

    xCures’ partnership with CureScience serves to better identify specific patients and patient populations that may benefit from a particular test or treatment.

    Visit CureScience

  • DTRA

    xCures is part of a historic alliance of close to a hundred life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.

    Visit DTRA

  • Endeavor

    xCures partnered with Endeavor to help enroll and screen for patients who might be eligible for their clinical trials

    Visit Endeavor

  • Fibro Fighters

    xCures is collaborating with the FibroFighters Foundation on an Observational Research Study to advance knowledge about FLHCC across the country. FLHCC is a rare cancer primarily affecting adolescents and young adults. Enroll Now

    Visit Fibro Fighters

  • Fibrolamellar Cancer Foundation

    The Fibrolamellar Cancer Foundation has partnered with xCures to drive fibrolamellar carcinoma (FLC) research and find treatment options for patients with FLC, a rare and often-fatal disease.

    Visit Fibrolamellar Cancer Foundation

  • Institute of Systems Biology

    xCures has partnered with the Institute of Systems Biology to develop innovative clinical trials to advance systems biology algorithms in glioblastoma and multiple myeloma.

    Visit Institute of Systems Biology

  • Massive Bio

     Massive Bio provides access to clinical trials for every cancer patient regardless of his/her location and/or financial stability.

    Visit Massive Bio

  • Novocure

    Novocure has partnered with xCures to better understand the experience and journey of patients diagnosed with glioblastoma. With xCures’ real-world data, Novocure is working to understand the links between patients’ quality of life and treatment decisions, disease characteristics, and other factors.

    Visit Novocure

  • Musella Foundation

    Visit Musella Foundation

  • Oncoceutics

    xCures and Cancer Commons collaborated with Oncoceutics to implement an Expanded Access program for ONC201

    Visit Oncoceutics

  • Patient Record Scorecard

    xCures is a supporter of the Ciitizen Patient Record Scorecard that shows how medical record providers comply with the HIPAA Right of Access based on patient requests.

    Visit Patient Record Scorecard


    xCures collaborates with POETIC, a non-profit organization that manages pediatric oncology early phase trials, to get children, adolescents, and young adults with cancer enrolled in expanded access programs of promising therapies. Learn More

    Visit POETIC